Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-10-057258
Filing Date
2010-03-15
Accepted
2010-03-15 17:31:13
Documents
9
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1121112
2 2010 CORPORATE BONUS PLAN dex1035.htm EX-10.35 48544
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 1728
4 CERTIFICATION OF CEO PURSUANT TO RULE 13A - 14(A) AND 15D-14(A) dex311.htm EX-31.1 9572
5 CERTIFICATION OF CFO PURSUANT TO RULE 13A - 14(A) AND 15D-14(A) dex312.htm EX-31.2 9749
6 CERTIFICATION OF CEO AND CFO PURSUANT TO 18.U.S.C. SECTION 1350 dex321.htm EX-32.1 5964
7 GRAPHIC g87154g62d10.jpg GRAPHIC 27455
8 GRAPHIC g87154g82l23.jpg GRAPHIC 24999
9 GRAPHIC g87154g99u41.jpg GRAPHIC 62044
  Complete submission text file 0001193125-10-057258.txt   1356273
Mailing Address 12481 HIGH BLUFF DRIVE SUITE 200 SAN DIEGO CA 92130
Business Address 12481 HIGH BLUFF DRIVE SUITE 200 SAN DIEGO CA 92130 8584361400
CADENCE PHARMACEUTICALS INC (Filer) CIK: 0001333248 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33103 | Film No.: 10682746
SIC: 2834 Pharmaceutical Preparations